This hot topic webinar focuses on the impact of unmanaged chronic hepatitis B on primary liver cancer. This is one of the biggest known risk factors and this webinar will assist with understanding the statistics and when to support surveillance and referral.
Learn from experts in liver cancer treatment and join us for presentations and discussion on liver cancer data with Hepatitis Queensland and Cancer Council Queensland.
Date, Time, Platform:
Date: Wednesday, 10th June 2026
Time: 6:30pm – 8:00pm (AEST)
Platform: Online – Zoom
CLICK HERE to download printable flyer for this event
Presenters:
- Dr Melita Andelkovic | Gastroenterologist and Hepatologist | Prince Alexandria Hospital
- Liver Well
- Cancer Council QLD
- Hepatitis Queensland
Learning Outcomes:
On completion of this course and its components, participants will be able to:
- Describe the global and local epidemiology of Hepatitis B and its link to Hepatocellular Carcinoma
- Recognise indications for liver cancer surveillance (e.g., ultrasound, AFP testing)
- Recognise early signs of malignancy and referral pathways
CPD & Endorsement:
- Attendees will receive a statement of attendance to self-submit to relevant endorsement bodies.
- HBV s100 Prescribers will receive 1 HBV Prescriber Point if they attend the duration of the webinar.
Funding:
- This activity is funded by Queensland Health.
Target Audience:
- This webinar is intended for all healthcare professionals that is interested in HBV and liver cancer working in QLD.
Help us keep ASHM courses free!
At ASHM, we are committed to developing a sustainable HIV, viral hepatitis, and sexual health workforce. We pride ourselves on the ability to offer high quality educational opportunities, that are free to attend. If you are unable to attend one of our courses, please let us know as soon as possible, high rates of non-attendance impacts ASHMs ability to continue providing free education. You can cancel your attendance by calling 0431 320 429 or emailing [email protected].
